aid: creyon-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/creyon-bio.png
name: Creyon Bio
description: >-
  Creyon Bio (branded Creyon) is a San Diego drug-development company operating an
  AI-powered nucleic acid engineering platform, NucleIQ, that designs oligonucleotide
  and RNA therapies with tissue- and cell-specific delivery. Creyon uses aptamer-based
  delivery, lipid nanoparticles, and transferrin-receptor aptamers to cross the
  blood-brain barrier, targeting immunology, central nervous system (CNS), and
  neuromuscular indications including late-onset Pompe disease. The company is a
  venture-backed portfolio company of DCVC and currently advances three wholly-owned
  programs. This profile is a company/identity record in the API Evangelist network;
  Creyon publishes no public developer API, SDKs, or API documentation.
url: https://raw.githubusercontent.com/api-evangelist/creyon-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Drug Development
- RNA Therapeutics
- Oligonucleotides
- Artificial Intelligence
- Life Sciences
- Nucleic Acid Engineering
apis: []
common:
- type: DomainSecurity
  url: security/creyon-bio-domain-security.yml
- type: Website
  url: https://creyon.com/
- type: Blog
  url: https://creyon.com/news/
- type: TermsOfService
  url: https://creyon.com/terms-of-use/
- type: PrivacyPolicy
  url: https://creyon.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/creyonbio/
- type: Twitter
  url: https://x.com/creyonbio
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence